Login
Login     |     Register     |     Recover Username/Password

General Investing

What’s your Investment Philosophy?

December 07, 2007

This week’s portfolio managers run the gamut of styles and philosophies. Here’s an idea of how they are managing their clients money:

  •  Jason Kiss, Bartlett & Co.: ” For most of our clients, we manage all or a vast majority of their assets and so our value methodology tends to be a bit more wide-ranging than any strict definition might allow. We look to have some sort of a discount on the typical valuation metrics that go along with value investing such as the p/e and a higher dividend yield; but we’re not going to be at an extremely steep discount to the S&P 500 or the Russell 1000. With the Index at a 15 p/e we’re not going to be at 10; we’re more likely to be at a 13.5 to 14.0 level simply because we don’t feel it’s prudent to take such a big style bet with our client
    assets.”
  • Martin Anstee, Stone Asset Managemnt: “The overall philosophy is attuned toward looking for growth situations. I look for growth and the other portfolio managers also look for growth. We have a lot of income-based products as well, which are mainly my products, but they are based not totally on dividend yield; they are based on growth as well.”
  • Steve Wilson, Lapides Asset Management: “We do research-differentiated value investing. I’d characterize our research as exceptionally deep. It’s also global; we travel around the world to understand our companies, even though all of our investments are domiciled in the US. We have one investment philosophy and process that drives three portfolios, which are segmented by concentration and capitalization. Our process is long-term oriented, opportunistic and contrarian. We focus exclusively on investing in smaller companies, those with capitalizations that range from $50 million to $10 billion. ”

For the full investment strategies issue, including complete interviews with all these portfolio managers, and more, click here.


TSWT - Subscribe now!

The Wall Street Transcript is a completely unique resource for investors and business researchers.

Over 20,000 CEO, Equity Analyst and Money Manager Interviews

TWST Newsletter

Weekly email with New In-Depth Interviews

Most Popular Interviews
Opportunities in Hepatitis C and Genomic Technologies
David Ferreiro

Published April 26, 2014 in Biotechnology and Pharmaceuticals

Buy ($75)
Investing in Health Care Innovation
Finny Kuruvilla

"We’re a faith-based and socially responsible investing firm"

Published May 16, 2013 in Investing in Health Care

Buy ($75)
A Health Sciences Fund with a Long-Term Focus
Mark W. Oelschlager

"The fund is about $40 million in assets"

Published May 16, 2013 in Investing in Health Care

Buy ($75)
High-Yield Canadian Power Companies
John McIlveen

Published May 14, 2013 in High-Yield Equity Securities

Buy ($75)
Most Popular Reports
Investing in Health Care

Published May 16, 2013

Topics Covered: Health Care - Electronic Health Record Adoption - Biotechnology and Pharmaceutical Investing - Biotechnology and Pharmaceuticals - Biotechnology and Pharmaceutical Companies Valuation - Platform Interoperability and Data Analytics - HITECH Act Incentives - Affordable Care Act
Buy ($175)
Internet Services

Published May 10, 2013

Topics Covered: Increased Mobile Content Traffic - Chinese Online Monetization Trends - Internet Infrastructure and Services Consolidation - Social Networking Economics -
Buy ($175)
Investing Strategies

Published May 10, 2013

Topics Covered: Investing in Financial Services - Long-Term Investing - Large Cap Investing - Value Investing - High Quality Companies - Bottom-up Investing - All-Cap Growth Investing - Investing in Emerging Markets
Buy ($175)
Top Company Interviews
TWST
Register for a Free Account to gain greater access to The Wall Street Transcript right now